[go: up one dir, main page]

WO2006007846A3 - Pansement - Google Patents

Pansement Download PDF

Info

Publication number
WO2006007846A3
WO2006007846A3 PCT/DK2005/000496 DK2005000496W WO2006007846A3 WO 2006007846 A3 WO2006007846 A3 WO 2006007846A3 DK 2005000496 W DK2005000496 W DK 2005000496W WO 2006007846 A3 WO2006007846 A3 WO 2006007846A3
Authority
WO
WIPO (PCT)
Prior art keywords
antioxidant
protease inhibitor
serine protease
dressing
spi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2005/000496
Other languages
English (en)
Other versions
WO2006007846A2 (fr
Inventor
Flemming Reissig Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Publication of WO2006007846A2 publication Critical patent/WO2006007846A2/fr
Publication of WO2006007846A3 publication Critical patent/WO2006007846A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'un inhibiteur de sérine protéase (SPI) en combinaison avec un antioxydant, afin d'obtenir un effet synergique et amélioré sur la cicatrisation de plaies, notamment de plaies chroniques, telles que les escarres de décubitus ou les ulcères de jambes. L'invention concerne également l'utilisation d'antioxydants en tant qu'éléments stabilisants au cours de la production, du transport, du stockage et de la stérilisation de compositions, telles que des compositions pharmaceutiques, ou de dispositifs médicaux, contenant des éléments pharmaceutiques actifs sensibles à l'oxydation, tels que les SPI.
PCT/DK2005/000496 2004-07-16 2005-07-14 Pansement Ceased WO2006007846A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401122 2004-07-16
DKPA200401122 2004-07-16

Publications (2)

Publication Number Publication Date
WO2006007846A2 WO2006007846A2 (fr) 2006-01-26
WO2006007846A3 true WO2006007846A3 (fr) 2006-02-23

Family

ID=35448116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2005/000496 Ceased WO2006007846A2 (fr) 2004-07-16 2005-07-14 Pansement

Country Status (1)

Country Link
WO (1) WO2006007846A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180289836A1 (en) 2017-04-05 2018-10-11 Drexel University Complexes and methods of reducing inflammation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190917A (en) * 1986-12-24 1993-03-02 John Lezdey Treatment of psoriasis
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
EP1270013A1 (fr) * 2000-02-15 2003-01-02 AlphaMed Pharmaceuticals Corporation Compositions topiques pour le traitement des plaies contenant de l'acide hyaluronique et un inhibiteur de sérine protéase

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190917A (en) * 1986-12-24 1993-03-02 John Lezdey Treatment of psoriasis
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
EP1270013A1 (fr) * 2000-02-15 2003-01-02 AlphaMed Pharmaceuticals Corporation Compositions topiques pour le traitement des plaies contenant de l'acide hyaluronique et un inhibiteur de sérine protéase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PUPPALA K C ET AL: "SERINE PROTEASE INHIBITORS PROFILES DISTINGUISH CHRONIC FROM ACUTE WOUNDS", JOURNAL OF INVESTIGATIVE DERMATOLOGY, NEW YORK, NY, US, vol. 108, no. 4, April 1997 (1997-04-01), pages 617, XP008017764, ISSN: 0022-202X *

Also Published As

Publication number Publication date
WO2006007846A2 (fr) 2006-01-26

Similar Documents

Publication Publication Date Title
MX2012002746A (es) Vendajes medicos antimicrobianos y proteccion de heridas y sitios de cateter.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
EP4110325A4 (fr) Formulations pharmaceutiques transdermiques et/ou topiques comprenant du cannabidiol et/ou du tétrahydrocannabinol pour le traitement de la douleur chronique
WO2004089380A3 (fr) Utilisation pharmaceutique de 1,2,4-triazoles fusionnes
TW200605870A (en) Topical methadone compositions and methods for using the same
WO2007051811A3 (fr) Utilisation pharmaceutique d'amides substitues
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
US7728188B2 (en) Methods and compositions for topical wound treatment
SI1901755T1 (sl) Novi farmacevtski sestavki, ki vsebujejo hialuronsko kislino ali njene derivate in kolagenazo, za topično zdravljenje ran, opeklin in ulkusov
SE0950392L (sv) Sammansättning för behandling av hudåkommor
WO2007075695A3 (fr) Utilisation de derives de sulfamide heterocyclique benzo-fusionne pour le traitement de la manie et du trouble bipolaire
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
WO2001089536A3 (fr) Entites apoptotiques destinees a etre utilisees pour le traitement de troubles inflammatoires lies aux lymphocytes t
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
WO2006007846A3 (fr) Pansement
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
NZ515933A (en) Ceruloplasmin and composition comprising pyruvate, lipid and an antioxidant (vitamin E)
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2002017952A3 (fr) Inhibition de la voie de la proteine mapkkk: une strategie therapeutique selective contre les melanomes
WO2003020304A3 (fr) Compose modulateur d'inflammation
WO2006026604A3 (fr) Méthodes favorisant la guérison de plaies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase